RT @CardioNowNews: POISE: One year outcomes: of P

RT @CardioNowNews: POISE: One year outcomes: of Peri-Op Beta Blocker in Patients Undergoing Non-cardiac Surgery - Incr. Mortality and Stro…

  • 22 May

    Study finds newly discovered anti-Mxra8 antibodies may be key to effectively treat chikungunya and other alphavirus… https://t.co/srW4aDWd13

  • 22 May

    RT: Clinical Trials Day helps raise clinical trial awareness and honors clinical research professionals by recognizing their c…

  • 20 May

    states new outbreak is not yet a top health emergency https://t.co/UTQndfDEmA

  • 20 May

    F.D.A. approves monthly injection monoclonal antibody, Aimovig, for migraine prevention. Is the $6,900 annual price… https://t.co/zSASlNHTnq

  • 20 May

    COMPASS analysis: After major adverse limb event, risk of death increases by 3 times, and risk of amputation increa… https://t.co/dhX2cyswB9

  • 20 May

    Similar mortality between restrictive fluid and liberal fluid regimens in patients at increased risk for complicat… https://t.co/9oEcmIDK5l

  • 18 May

    Efficacy of Trastuzumab for 6 months similar to 12 months in breast cancer, less adverse effects.… https://t.co/g4iUJcQxIZ

  • 17 May

    Addition of cannabidiol to conventional antiepileptic regimen results in greater reductions in the frequency of dro… https://t.co/Pe0gYTjeEr

  • 17 May

    SYGMA 1 trial: In patients with mild asthma, as-needed budesonide–formoterol superior to terbutaline… https://t.co/pgKr5zeF38

  • 16 May

    More than 300,000 cases of chlamydia, gonorrhea, and early syphilis were reported: a 45% increase compared to five… https://t.co/C1n0ti4BmK